HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

483.092

+7.3581.55%

Number of Gainers:30

Number of Losers:17

Number of Flat:4

PE:- -

High:489.935

Open:476.052

Low:476.052

Close:475.733

Volume:488.38M

Turnover:15.69B

Market Cap:3.05T

Float Cap:2.14T

Loading ...

Junshi Biosciences Reports First-Half Net Profit of RMB21.66 Million, Reversing Year-Earlier Loss

Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption

Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned as CEO

MP CARDIOFLOW-B Announces New Leadership Appointments

MicroPort CardioFlow Delays Board Meeting on Interim Results Release

MicroPort CardioFlow Files Board and Committee Member List with Disclosure Roles

Microport Cardioflow Medtech - Zhang Ruinian Has Resigned as Chief Executive Officer, Appointed as President

THOMSON REUTERS

Microport Cardioflow Medtech - Brian Chang Has Been Appointed as Chairman

THOMSON REUTERS

MicroPort CardioFlow Names Chen Guoming CEO, Replacing Zhang Ruinian

Stronger Half Year Earnings And Profitability Could Be A Game Changer For Hansoh (SEHK:3692)

Simply Wall St.

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

Microport Scientific - Shanghai Microport Endovascular Medtech Hy Revenue of Rmb793.95 Mln

THOMSON REUTERS

Conch Cement Reports Interim Results with 41.85% Decline in Shareholder Profit

Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve

Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share

AK MEDICAL Reports 22.5% Profit Surge in Interim Results

AK Medical Holdings H1 Net Income Attributable RMB 196.7 Million

THOMSON REUTERS

AK Medical FY26 H1 Profit Rises 22.5% to RMB 196.72 Million; Revenue Climbs 10.2% to RMB 764.73 Million

BAIRONG AI-W (06608) Finalizes Placement of 37.39 Million Warrants

Bairong Completes Placement of 37,393,500 Non-Listed Warrants at Hk$0.29 Each

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/stock/BK1583/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":483.09152,"timestamp":1787731681268,"preClose":475.73328,"halted":0,"volume":488382885,"delay":0,"changeRate":0.015467,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":7.358246,"latestTime":"08-26 16:00:00","open":476.05173,"high":489.9351,"low":476.05173,"amount":15692759792,"amplitude":0.029183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787794200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"pbRate":2.190954,"peRate":45.887856,"turnoverRate":0.00444,"increases":29,"decrements":17,"flats":5,"marketCap":3046612092000,"floatMarketCap":2135803070880},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":489.9351,"amplitude":0.029183,"preClose":475.73328,"low":476.05173,"pbRate":"2.190954","latestPrice":483.09152,"volume":488382885,"delay":0,"open":476.05173,"prevYearClose":503.90085,"prevWeekClose":492.216,"prevMonthClose":470.497,"prevQuarterClose":402.118,"fiveDayClose":485.91,"twentyDayClose":476.698,"sixtyDayClose":436.706,"secType":"PLATE","market":"HK","turnoverRate":0.00444,"peRate":45.887856,"marketCap":3046612092000,"floatMarketCap":2135803070880,"timestamp":1787731681268,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":30,"down":17,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1178598132","title":"Junshi Biosciences Reports First-Half Net Profit of RMB21.66 Million, Reversing Year-Earlier Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1178598132","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178598132?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:20","pubTimestamp":1787761218,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. has announced its financial results for the first half of 2026, revealing a notable turnaround in profitability.During the reporting period, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1161","01877","BK1515","688180","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163553180","title":"Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption","url":"https://stock-news.laohu8.com/highlight/detail?id=1163553180","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163553180?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:30","pubTimestamp":1787758250,"startTime":"0","endTime":"0","summary":"Boston Scientific disclosed in a Wednesday filing with the U.S. Securities and Exchange Commission (SEC) that it has been struck by a cyberattack, impacting its business operations. The incident is...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2244417387.USD","LU2112291526.USD","BK1574","BK4588","MEDX","LU0823416689.USD","LU1791710582.SGD","RSPH","HAKY","LU1718418525.SGD","IEIH","SG9999001176.USD","WCBR","IE00B2B36J28.USD","LU1989764664.SGD","LU2324357040.USD","SGXZ57979304.SGD","PTH","BK4581","LU0950375773.USD","LU2491050071.SGD","LU2362540622.SGD","BK1100","IE0002141913.USD","LU1804176565.USD","LU0345769631.USD","LU2357305700.SGD","LU0882574055.USD","LU0238689110.USD","LU1291159041.SGD","HART","LU1720051108.HKD","LU0011850046.USD","LU0267386448.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4504","LU0353189763.USD","LU2491049909.HKD","LU0077335932.USD","LU0251132253.USD","LU0345769128.USD","LU0138981039.USD","LNGR","LU0187121727.USD","LU1989764748.USD","SG9999001176.SGD","LU0114720955.EUR","09996","LU0225283273.USD","LU1989772840.SGD","LU0528227936.USD","IE00BJT1NW94.SGD","LU1720051017.SGD","SPAM","LU1057294990.SGD","LU1791710400.SGD","BK4082","LU1061106388.HKD","GDOC","LU0353189680.USD","LU0823417653.USD","LU1548497426.USD","LU2506952170.USD","LU1983299246.USD","LU0823417737.USD","LGHT","BSX","LU0122379950.USD","LU2506952097.USD","UCYB","LU1153585028.USD","LU2265009873.SGD","LU2506951958.HKD","LU1989772923.USD","LU1989771016.USD","BK4585","LU2362541273.HKD","LU2362541513.USD","LU0432979614.USD","MDEV","LU2491050154.USD","LU0266013472.USD","SG9999013999.USD","IE0009355771.USD","LU0048584097.USD","LU2506951875.HKD","LU2087625088.SGD","AGNG","159883","IE00B4R5TH58.HKD","LU1023059063.AUD","BK1583","LU1366192091.USD","LU2242649171.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662106748","title":"Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2662106748","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662106748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:08","pubTimestamp":1787756895,"startTime":"0","endTime":"0","summary":"BRIEF-Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned As CEOAug 26 -Microport Cardioflow Medtech Corp2160.HK:ZHANG RUINIAN HAS RESIGNED AS CHIEF EXECUTIVE OFFICER, APPOINTED AS PRESIDENTCHEN GUOMING RESIGNED AS CHAIRMAN, RE-DESIGNATED TO EXECUTIVE DIRECTOR, APPOINTED AS CEOBRIAN CHANG HAS BEEN APPOINTED AS CHAIRMANFurther company coverage:2160.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1100","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128341122","title":"MP CARDIOFLOW-B Announces New Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=1128341122","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128341122?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:02","pubTimestamp":1787756533,"startTime":"0","endTime":"0","summary":"MP CARDIOFLOW-B (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1225","BK1100","BK1574","BK1583","02160","02918","BK1239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662573748","title":"MicroPort CardioFlow Delays Board Meeting on Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2662573748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662573748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756331,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow delays board meeting on interim results releaseMicroPort CardioFlow Medtech rescheduled its board meeting to Aug. 31, 2026, from Aug. 26, 2026.Session will review interim results ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL6mSG1y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","00853","02160","BK1589","BK1585","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662574857","title":"MicroPort CardioFlow Files Board and Committee Member List with Disclosure Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2662574857","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662574857?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756324,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow files board and committee member list with disclosure rolesMicroPort CardioFlow Medtech (2160) updated its board and committee lineup in a filing dated Aug. 26, 2026.Brian Chang l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7XTd8n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1585","00853","BK1574","BK1583","BK1589","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748578","title":"Microport Cardioflow Medtech - Zhang Ruinian Has Resigned as Chief Executive Officer, Appointed as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748578","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748578?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756316,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","02160","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662485717","title":"Microport Cardioflow Medtech - Brian Chang Has Been Appointed as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2662485717","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662485717?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756316,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02160","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748576","title":"MicroPort CardioFlow Names Chen Guoming CEO, Replacing Zhang Ruinian","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748576","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748576?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756289,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow names Chen Guoming CEO, replacing Zhang RuinianMicroPort CardioFlow Medtech named Guoming Chen chief executive, replacing Ruinian Zhang, effective Aug. 26, 2026.Chen stepped down ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLb6bRcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","BK1583","BK1589","BK1585","00853","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745499","title":"Stronger Half Year Earnings And Profitability Could Be A Game Changer For Hansoh (SEHK:3692)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745499","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745499?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:20","pubTimestamp":1787754056,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited has reported past half-year results to June 30, 2026, with sales rising to CNY 8,304.01 million and net income increasing to CNY 4,257.94 million, lifting basic and diluted EPS from continuing operations to CNY 0.70.\nThe combination of higher revenue and a larger increase in net income suggests improved profitability and operating efficiency in Hansoh’s core business.\nWe will now explore how this improvement in earnings and profitability shapes...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/stronger-half-year-earnings-and-profitability-could-be-a-gam","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/stronger-half-year-earnings-and-profitability-could-be-a-gam","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1589","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662717592","title":"Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717592","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662717592?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:54","pubTimestamp":1787752465,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical H1 revenue rises on nuclear medicine demandOverviewHong Kong-listed pharma group's H1 revenue rose 3.2% yr/yr to HK$6.39 blnNet income attributable to owners fell to HK$1.06 bln f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","03692","00512","00460","BK1593","BK1600","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662173427","title":"Microport Scientific - Shanghai Microport Endovascular Medtech Hy Revenue of Rmb793.95 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173427?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:50","pubTimestamp":1787752239,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1585","00853","BK1589","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116288019","title":"Conch Cement Reports Interim Results with 41.85% Decline in Shareholder Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1116288019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116288019?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:30","pubTimestamp":1787751055,"startTime":"0","endTime":"0","summary":"Conch Cement (00914) has released its interim results for the six-month period ended June 30, 2026. The group recorded operating revenue of RMB 36.927 billion, a year-on-year decrease of 10.88%....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1563","BK1594","LU1328615791.USD","BK0235","BK0187","BK1505","BK1507","BK1583","BK0012","BK1135","BK0028","BK0196","BK0015","600585","BK0044","BK0183","BK0188","00914"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184470015","title":"Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve","url":"https://stock-news.laohu8.com/highlight/detail?id=1184470015","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184470015?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:28","pubTimestamp":1787750895,"startTime":"0","endTime":"0","summary":"Lee's Pharmaceutical Holdings Ltd (00950) has issued a positive profit alert, indicating that the group expects to report an audited net profit attributable to shareholders of between approximately...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","00950","BK1587","06622","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279711","title":"Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279711","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662279711?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:46","pubTimestamp":1787748384,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical cuts convertible bond conversion price to HK$56.54 per shareHansoh Pharmaceutical adjusted the conversion price on its HK$ 4.68 billion zero-coupon convertible bonds due 2033.Con","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLc9h2j6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1191","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170704019","title":"AK MEDICAL Reports 22.5% Profit Surge in Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1170704019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170704019?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:32","pubTimestamp":1787747544,"startTime":"0","endTime":"0","summary":"AK MEDICAL (01789) has released its interim results for the 2026 fiscal year, posting a revenue of approximately HK$765 million, reflecting a year-on-year increase of 10.2%.The company's profit...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","BK1100","BK1583","BK1585","01789"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662719438","title":"AK Medical Holdings H1 Net Income Attributable RMB 196.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662719438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662719438?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:20","pubTimestamp":1787746844,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nPLX2N4ZLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1585","BK1583","BK1100","01789","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662719443","title":"AK Medical FY26 H1 Profit Rises 22.5% to RMB 196.72 Million; Revenue Climbs 10.2% to RMB 764.73 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662719443","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662719443?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:20","pubTimestamp":1787746844,"startTime":"0","endTime":"0","summary":"AK Medical FY26 H1 profit rises 22.5% to RMB 196.72 million; revenue climbs 10.2% to RMB 764.73 millionAK Medical posted profit attributable to equity shareholders of RMB 196.72 million, up 22.5%, wit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLblfxzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1617","BK1583","BK1100","01789"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187859653","title":"BAIRONG AI-W (06608) Finalizes Placement of 37.39 Million Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=1187859653","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187859653?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:00","pubTimestamp":1787745623,"startTime":"0","endTime":"0","summary":"BAIRONG AI-W (06608) has announced that all conditions precedent for the placement have been fulfilled, and the placement was completed on August 26, 2026, in accordance with the terms and conditions...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK1109","06608","BK1131","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662716305","title":"Bairong Completes Placement of 37,393,500 Non-Listed Warrants at Hk$0.29 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2662716305","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662716305?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:55","pubTimestamp":1787745353,"startTime":"0","endTime":"0","summary":"Bairong completes placement of 37,393,500 non-listed warrants at HK$0.29 eachBairong completed a placing of 37,393,500 non-listed warrants under a specific mandate on Aug. 26, 2026.Warrants placed at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL370TWx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1109","BK1131","BK1583","BK1575","06608","BK1587"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":1,"totalSize":426,"code":"91000000","status":"200"}]}}